– Electrek
https://electrek.co/2022/08/31/tesla-tsla-facing-unprecedented-demand/
Allogene Therapeutics Announces Encore Presentation Of Phase 1 Data From The ALLO-501/501A Trials In Large B Cell Lymphoma At The European Hematology Association Hybrid Congress
Data Will Also Be Presented in a Poster Session at the American Society of Clinical Oncology (ASCO) Annual Meeting on June 3, 2023
SOUTH SAN FRANCISCO, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- Allogene Therapeutics,
